Letters National HPV vaccination

Authors’ reply to Gupta

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f3734 (Published 11 June 2013) Cite this as: BMJ 2013;346:f3734
  1. Basil Donovan, professor1,
  2. Hammad Ali, lecturer1
  1. 1Kirby Institute, University of New South Wales, Sydney NSW 2052, Australia
  1. bdonovan{at}kirby.unsw.edu.au

Gupta asks why the national human papillomavirus (HPV) vaccination programme in Australia doesn’t cover women undergoing treatment for high grade cervical disease.1 2

The quadrivalent HPV vaccine was not designed to act as a therapeutic vaccine and theoretically provides no benefit against an existing HPV infection—just as the flu vaccine doesn’t benefit people with flu. Interestingly, a retrospective analysis of data from two randomised placebo controlled trials showed reduced recurrence of …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe